📰 Michael Erman News
Page 80 - Michael Erman News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Erman. Real-time updates on events, politics, business and more.
August 11, 2021
NEW YORK (Reuters) - Antibody levels are a good predictor for how effective Moderna Inc's COVID-19 vaccine is, according to a new study released on Tu...
August 11, 2021
HEALTH-CORONAVIRUS/USA-CDC (URGENT, PIX):CDC recommends pregnant women get COVID-19 vaccine
August 3, 2021
By Syndicated Content By Francesco Guarascio BRUSSELS (Reuters) – The European Union has agreed to pay a premium on new orders of COVID-19 vaccines because it is requiring tougher terms to be met, European officials said, as the bloc tries to protect supplies after a rocky start to its vaccination campaign. The higher price is less than the United States has agreed to pay in its latest order in July. On Sunday, the Financial Times reported the EU has agreed to pay Pfizer and BioNT...
July 27, 2021
Pfizer and BioNTech Agree to Vaccine Technology Transfer with South Africas Biovac Institute As reported by Reuters* on Wednesday ( e"), Pfizer and BioNTech, manufacturers and developers of an mRNA-based vaccine against SARS-CoV-2, have agreed to help the South African drug maker Biovac Institute produce about 100 million doses per year of its vaccine, specifically to be targeted to African nations. As described by the Reuters article, Biovac Institute is "a joint venture between the South Afri...
July 24, 2021
U.S. buys 200M more doses of Pfizer/BioNTech COVID-19 vaccine The deal comes as the Delta variant of the coronavirus sweeps across the country and drives up infections, contributing to the debate over whether or not Americans will need a booster dose this fall. Written By: Manas Mishra and Michael Erman / Reuters | 2:44 pm, Jul. 23, 2021 × A medical worker prepares a dose of the Pfizer-BioNTech "Comirnaty" vaccine against the coronavirus disease (COVID-19) in a vaccinatio...
July 21, 2021
Article content “We thought that this was the right place to create this capability, a capability that can be used for a public health emergency like COVID-19.” The company plans to install two 2,000-liter single-use bioreactors at the Agnani plant, as well as the infrastructure required for another six 2,000-liter single-use bioreactors. Catalent acquired the Agnani plant from Bristol Myers Squibb in January 2020 and quickly signed deals to fill and finish the AstraZeneca and J&J vaccines ...
July 13, 2021
Article content J&J and the FDA were not immediately available for comment. GBS is a rare neurological condition in which the body’s immune system attacks the protective coating on nerve fibers. Most cases follow a bacterial or viral infection. The condition has been linked in the past to vaccinations – most notably to a vaccination campaign during a swine flu outbreak in the United States in 1976, and decades later to the vaccine used during the 2009 H1N1 flu pandemic. Last week, European ...
July 9, 2021
Article content Pfizer Chief Scientific Officer Mikael Dolsten said the recently reported dip in the vaccine’s effectiveness in Israel was mostly due to infections in people who had been vaccinated in January or February. The country’s health ministry said vaccine effectiveness in preventing both infection and symptomatic disease fell to 64% in June. We apologize, but this video has failed to load. Try refreshing your browser, or Pfizer to ask FDA to authorize booster dose of COVID vaccine...
July 9, 2021
 "; $(function(){ $.each($(".autopromo"),function(index,elmnt){ $(elmnt).css("display",""); $(elmnt).html(sHTMLAutopromo); }); if(window.screen.width Pfizer va demander à la FDA dautoriser un rappel supplémentaire de son vaccin pour lutter contre le variant Delta 09/07/2021 | 01:16 1 Message personnel : par Michael Erman et Julie Steenhuysen NEW YORK, 9 juillet (Reuters) - Pfizer prévoit de demander à la Food and Drug Admi...
July 9, 2021
Publishing date: Jul 08, 2021 • 11 hours ago • 4 minute read • A vial and syringe are seen in front of a displayed Pfizer and Biontech logo in this illustration taken Jan. 11, 2021. The vaccine presents a "significant oppotunity" to make profits after the pandemic is over, executive says. Photo by Dado Ruvic / Reuters Article content NEW YORK — Pfizer Inc plans to ask U.S. regulators to authorize a booster dose of its COVID-19 vaccine within the next month, the drugmake...